• Mr.Bruce Li
    Tel: +86-027-83214688

  • Ms.Linda Yang
    sales
    Tel: +8618874586545

  • Ms.Niyoe Tan
    sales
    Tel: 17720330692

  • Ms.rany
    Tel: +8618627068784

  • Ms.Yuki
    Tel: +8618871152735

  • Mobile:
  • Tel:+86-027-83214688
  • Fax:02783214688
  • Province/state:Hubei
  • City:Wuhan
  • Street:666 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province, China
  • MaxCard:
Home > Products >  White Powder Pharmaceutical Material Methylprednisolone Anti Estrogen Steroids For Rheumatoid Arthritis

White Powder Pharmaceutical Material Methylprednisolone Anti Estrogen Steroids For Rheumatoid Arthritis CAS NO.83-43-2

  • Min.Order: 10 Gram
  • Payment Terms: T/T,
  • Product Details

Keywords

  • 99% Methylprednisolone
  • Pharmaceutical intermediates
  • Sterols Hormone

Quick Details

  • ProName: White Powder Pharmaceutical Material M...
  • CasNo: 83-43-2
  • Molecular Formula: C22H30O5
  • Appearance: White Powder
  • Application: It Can Be Used As Pharmaceutical Inte...
  • DeliveryTime: 2-4 days after confirming your payment...
  • PackAge: 100g/ bag, 2 kg/ bag, 25kg/ carton or ...
  • Port: Shanghai
  • ProductionCapacity: 10000 Metric Ton/Month
  • Purity: 99%
  • Storage: Store in sealed containers at cool & d...
  • Transportation: By DHL, TNT, FedEx, HKEMS, UPS, Etc
  • LimitNum: 10 Gram

Superiority

 

Advantages:
 
Hubei XinRunde Chemical Co., Ltd is a renowned pharmaceutical manufacturer. We can offer high quality products at competitive price in quick delivery with 100% custom pass guaranteed. Never stop striving to offer our best service is our philosophy. We have Flexible and Untraceable payment terms. As a leading manufacture, our products have been exported to Germany, Norway, Poland, Finland, Spain, UK, France, Russia, USA, Brazil, Mexico, Australia, Japan, Korea, Thailand, Indonesia, Uruguay and many other countries.

 

1. Quality.Every batch of steroid powders have tobetested by our QC(quality control) before they are allowed to sell.


2. Delivery We have stock, so we can delivery quickly at the very day when receive the payment. Within 24 hours after receiving the payment Lead time 4 or 7 days.


3. Discreet package Safelyand Professionally Disguised Package Guaranteed. For your safety and to insure delivery all products will be packed in a discreet way to prevent any suspicions, no steroids related name will appear on the parcels. high successful delivery rate.


4. Warm after-sale service Any of your question would be solved for the first as soon as possible.

 

Details

 

White Powder Pharmaceutical Material Methylprednisolone Anti Estrogen Steroids For Rheumatoid Arthritis CAS 83-43-2

 

Methylprednisolone

CAS:83-43-2

MF:C22H30O5

MW:374.47

EINECS:201-476-4

Synonyms:(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione;11,17,21-trihydroxy-6-methyl-1,4-pregnadiene-3,20-dione ;11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione;11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione;1-dehydro-6alpha-methylhydrocortisone ;20-dione,11,17,21-trihydroxy-6-methyl-,(6alpha,11beta)-pregna-4-diene-3 ;20-dione,11-beta,17,21-trihydroxy-6-alpha-methyl-pregna-4-diene-3 ;20-dione,11beta,17,21-trihydroxy-6alpha-methyl-pregna-4-diene-3

Properties

Melting point:228-237°C (dec.)

alpha D20 +83° (dioxane)

refractive index 82 ° (C=1, Dioxane)

storage temp. 0-6°C

solubility chloroform/methanol (9:1): 50 mg/mL, clear, faintly yellow

Merck 6111


Application


1. Anti-inflammatory treatment:

(rheumatic disease: as a short-term adjunct) (to help patients pass through acute or critical periods):

Posttraumatic osteoarthritis; synovitis caused by osteoarthritis; rheumatoid arthritis, juvenile rheumatoid arthritis (individual patients may need low dose maintenance treatment); acute or subacute bursitis; ankle arthritis; acute nonspecific tendon sheath inflammation; acute gouty arthritis; psoriatic arthritis; ankylosing spondylitis.

Collagen disorder (immune complex disease): critical illness or maintenance therapy for the following diseases:

Systemic lupus erythematosus (lupus nephritis); acute rheumatic myocarditis; systemic dermatomyositis (PM); polyarteritis nodosa; Goodpasture syndrome (Good pasture 's Syndrome). Skin disease: pemphigus; severe erythema multiforme (Stevens-Johnson syndrome); exfoliative dermatitis; bullous dermatitis herpetiformis; severe seborrheic dermatitis; severe psoriasis; mycosis fungoides; urticaria.

Allergy status: used to control the following to conventional treatment to deal with the serious damage caused by function or allergic diseases; bronchial asthma; contact dermatitis; atopic dermatitis; serum sickness; seasonal or perennial allergic rhinitis; allergic reaction; urticarial transfusion reaction; edema of acute non infective throat (epinephrine is the drug of choice).

- eye disease: severe acute and chronic ocular allergy and inflammation, such as herpes zoster; iritis, iridocyclitis; chorioretinitis; diffusion type real uveitis and choroiditis; optic neuritis; sympathetic ophthalmia.

Gastrointestinal disease: a critical period for patients to survive the following diseases; ulcerative colitis (systemic therapy); localized enterocolitis (systemic therapy). Respiratory disease: pulmonary sarcoidosis; beryllium poisoning;

Combined with appropriate anti tuberculosis chemotherapy for fulminant or diffuse tuberculosis;

Other methods cannot control Loeffler's syndrome (Loffler s Syndrome); aspiration pneumonia.

Edema: diuretic and urinary proteinuria for spontaneous or lupus nephrotic syndrome without uremia.

2. Immunosuppressive therapy: organ transplantation.
3. The treatment of blood diseases and tumors:

- blood diseases: acquired (autoimmune hemolytic anemia); adult idiopathic thrombocytopenic purpura (only intravenous injection, intramuscular injection of taboo); adult secondary thrombocytopenia; erythroblastopenia (anemia); congenital (red blood cell) aplastic anemia.

Tumor: palliative care for the following diseases; adult leukemia and lymphoma; childhood acute leukemia

4. Treatment shock:

Adrenal cortical insufficiency induced by shock, or because of adrenal cortical insufficiency and the shock had no response to conventional therapy (hydrocortisone for commonly used drugs; if you do not want to have the mineralocorticoid activity, using methylprednisolone).

Hemorrhagic, traumatic, and surgical shock without response to conventional therapy. Although there is no perfect (double-blind) clinical research, but animal experiment data show possible methylprednisolone to conventional therapy (e.g., rehydration) invalid effective shock. See also section of "infectious shock" in "precautions".

5. Other:

Nervous system:

Brain edema caused by primary or metastatic tumor, and (or) surgery and radiotherapy; acute severe stage of multiple sclerosis; acute spinal cord injury. Treatment should begin within 8 hours after trauma.

- combined with appropriate antituberculous therapy for tuberculous meningitis with subarachnoid obstruction or occlusion.

- involving nerve or myocardial trichinelliasis.

- prevention of nausea and vomiting caused by cancer chemotherapy.

6. Endocrine disorders:

Primary or secondary adrenal insufficiency;

Acute adrenocortical insufficiency;

(the above disease hydrocortisone or hydrocortisone as the drug of choice, if necessary, can be combined with synthetic glucocorticoid and mineralocorticoid.)

Patients who are known to have or may have adrenal insufficiency are administered before surgery and with severe trauma or disease.

Congenital adrenal hyperplasia; non suppurative thyroiditis; cancer induced hypercalcemia.

 

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog